Paul Seaman

Head of CMC

BSc, PhD, MRSB

Paul brings over two decades of pharmaceutical R&D experience to Relevium Medical. Through his consultancy, 3D Pharma Consulting Ltd, Paul provides technical oversight of CMC activities across Relevium’s platform and pipeline. Since 2001, he has worked across Big Pharma, Speciality Pharma, and start-ups, including GlaxoSmithKline, Q Chip Ltd, and Midatech Pharma PLC, where he served as VP Pharmaceutical & Technology Development, overseeing pharmaceutical development and CMC across three drug delivery technology platforms. He holds a PhD in Pharmaceutical Microbiology and has led drug programs from bench to clinic. He has broad regulatory experience including MHRA, EMA, BfArM, SwissMedic, and US FDA submissions. Paul specialises in emerging drug delivery technologies and brings substantial knowledge of sterile injectable drug product development. As Head of CMC, Paul leads Relevium Medical’s manufacturing, formulation, and quality strategy.